Status:

UNKNOWN

Prophecy Guide Outcomes in Total Knee Replacement Surgery

Lead Sponsor:

Global Orthopaedic Technology

Collaborating Sponsors:

LSS Surgical Pty Ltd

Conditions:

Osteoarthritis of the Knee

Total Knee Replacement

Eligibility:

All Genders

65-85 years

Phase:

PHASE4

Brief Summary

This project aims to assess two different techniques used to position the knee replacement implant during surgery. The patients will be randomised to receive either the following: 1. The established ...

Detailed Description

Knee joint pain is often the cause of reduced joint and limb function. Total knee joint replacement is a procedure which aims to relieve pain and help to improve mobility. There has been continued dev...

Eligibility Criteria

Inclusion

  • Patients requiring a total Knee Arthroplasty as determined jointly by the surgeon and the patient.
  • Over 65 years of age at time of surgery.
  • Patients with the Varus or Valgus Osteoarthritis
  • Patients who understand the conditions of the study and are willing to participate for the length of the prescribed term of follow-up.
  • Patients who are capable of, and have given, informed consent to their participation in the study.
  • The individual does not have an active infection within the affected joint.
  • The individual has not had a previous total knee replacement or knee fusion of the affected knee joint.
  • The individual is skeletally mature.
  • The individual is not pregnant.
  • The individual is not a prisoner.
  • The individual has no plans to relocate to another geographic area before the completion of the study.

Exclusion

  • Previous surgery requiring implanting a device.
  • Knee deformity is \>30° anatomic varus (as measured on an AP radiograph taken with the patient standing)
  • Knee deformity is \>30° anatomic valgus (as measured on an AP radiograph taken with the patient standing) \>20° knee flexion contracture (as measured by investigator examination)
  • Those patients requiring bone grafting or any other procedure that would extend the operative time beyond that of just replacing the knee should be excluded.
  • The individual is classified as morbidly obese (\>40 BMI).
  • The individual is physically or mentally compromised (i.e., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, presence of alcohol or substance abuse), and is unwilling or unable to comply with postoperative scheduled clinical and radiographic evaluation and rehabilitation.
  • The individual has a neuromuscular or neuro-sensory deficiency which limits the ability to evaluate the safety and effectiveness of the device.

Key Trial Info

Start Date :

August 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2017

Estimated Enrollment :

188 Patients enrolled

Trial Details

Trial ID

NCT01163708

Start Date

August 1 2010

End Date

December 1 2017

Last Update

July 29 2010

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Holy Spirit Northside Private Hospital

Chermside, Queensland, Australia, 4032

2

Prince Charles Hospital

Chermside, Queensland, Australia, 4032